Appropriate delay of primary tumour radiotherapy may lead to better long-term overall survival for non-small cell lung cancer treated with EGFR-TKIs
Authors (first, second and last of 9)
Collection
Advances in personalized radiotherapy
BMC Cancer is calling for submissions to our Collection on Advances in personalized radiotherapy. We welcome studies that aim to improve clinical outcomes following radiotherapy by the personalization of treatment as well as further understanding of radiosensitivity and the development of biomarkers.
Editors
-
Venkata SK. Manem: University of Quebec at Trois-Rivières, Canada
Dr. Venkata Manem is a Professor Sous Octroi in the Department of Mathematics and Computer Science at the Université du Québec à Trois Rivières and an early-career researcher at the Quebec Heart & Lung Institute (IUCPQ) as well as an Adjunct Professor at the Faculty of Pharmacy at Université Laval. Dr. Manem’s research expertise is to employ AI and statistical tools with the aim to develop data-driven diagnostic and predictive biomarkers by integrating high-dimensional data from various sources.
-
Farzad Taghizadeh-Hesary: Iran University of Medical Sciences, Iran
Farzad Taghizadeh-Hesary, M.D., is an Assistant Professor of Radiation Oncology at the Iran University of Medical Sciences (IUMS). His familiarity with the research methodologies has enabled him to conduct various research types, such as meta-analysis, systematic review, clinical trial, and prospective and retrospective studies. His areas of expertise are radiation oncology, radiation biology, medical oncology, and cancer biology.
Articles (11 in this collection)
-
-
Higher immune cell radiation dose is correlated with poor tumor control and survival in patients with non-small cell lung cancer receiving postoperative radiotherapy
Authors (first, second and last of 13)
-
A new approach to prevent radiation-induced xerostomia using intraglandular injection of mitochondria-boosting agents
Authors (first, second and last of 4)
-
-
Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery
Authors (first, second and last of 5)
-
Plasma extracellular vesicles in meningioma patients following radiotherapy as liquid biopsy- a prospective explorative biomarker study (ARO 2023-05/AG-NRO-07)
Authors (first, second and last of 22)
-
Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma
Authors (first, second and last of 25)
-
Rational and design of prophylactic cranial irradiation (PCI) and brain MRI surveillance versus brain MRI surveillance alone in patients with limited-stage small cell lung cancer achieving complete remission (CR) of tumor after chemoradiotherapy: a multicenter prospective randomized study
Authors (first, second and last of 9)
-
Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab era
Authors (first, second and last of 14)
-
Gene expression signature predicts radiation sensitivity in cell lines using the integral of dose–response curve
Authors (first, second and last of 4)
-
Shooting the messenger: a systematic review investigating extracellular vesicle isolation and characterisation methods and their influence on understanding extracellular vesicles-radiotherapy interactions in glioblastoma
Authors (first, second and last of 6)
